mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?

  • Veerle P W M Wijtvliet
  • , Kevin K Ariën
  • , Steven Abrams
  • , Marie M Couttenye
  • , Fabienne Mestrez
  • , Joachim Mariën
  • , Benedicte Y De Winter
  • , Pierre Van Damme
  • , Lissa Pipeleers
  • , Karl Martin Wissing
  • , Daniel Abramowicz
  • , Kristien J Ledeganck

Research output: Contribution to journalA1: Web of Science-articlepeer-review

30 Downloads (Pure)
Original languageEnglish
JournalNephrology, Dialysis, Transplantation
Volume37
Issue number4
Pages (from-to)799-803
Number of pages5
ISSN0931-0509
DOIs
Publication statusPublished - 2022

Keywords

  • 2019-nCoV Vaccine mRNA-1273
  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • Humans
  • Kidney Transplantation
  • Renal Dialysis
  • Transplant Recipients

Cite this